STERIS Return on Investment 2010-2022 | STE

Current and historical return on investment (ROI) values for STERIS (STE) over the last 10 years.
STERIS ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2022-09-30 $0.15B $8.69B 1.58%
2022-06-30 $0.57B $9.27B 5.92%
2022-03-31 $0.43B $9.49B 4.36%
2021-12-31 $0.48B $9.80B 5.44%
2021-09-30 $0.42B $9.97B 5.46%
2021-06-30 $0.45B $9.84B 6.95%
2021-03-31 $0.55B $5.54B 10.78%
2020-12-31 $0.56B $5.59B 11.61%
2020-09-30 $0.56B $4.68B 12.18%
2020-06-30 $0.54B $4.51B 12.04%
2020-03-31 $0.54B $4.57B 11.95%
2019-12-31 $0.52B $4.53B 11.67%
2019-09-30 $0.45B $4.43B 10.15%
2019-06-30 $0.43B $4.46B 9.72%
2019-03-31 $0.41B $4.37B 9.37%
2018-12-31 $0.38B $4.36B 8.68%
2018-09-30 $0.42B $4.39B 9.33%
2018-06-30 $0.41B $4.42B 9.10%
2018-03-31 $0.40B $4.53B 8.89%
2017-12-31 $0.34B $4.54B 7.75%
2017-09-30 $0.27B $4.49B 6.11%
2017-06-30 $0.24B $4.44B 5.44%
2017-03-31 $0.23B $4.29B 5.14%
2016-12-31 $0.27B $4.28B 5.98%
2016-09-30 $0.29B $4.51B 6.32%
2016-06-30 $0.24B $4.60B 6.17%
2016-03-31 $0.21B $4.61B 6.58%
2015-12-31 $0.18B $4.63B 7.26%
2015-09-30 $0.20B $1.92B 11.06%
2015-06-30 $0.23B $1.79B 13.19%
2015-03-31 $0.23B $1.70B 13.30%
2014-12-31 $0.22B $1.69B 13.14%
2014-09-30 $0.21B $1.69B 13.25%
2014-06-30 $0.21B $1.73B 13.45%
2014-03-31 $0.21B $1.54B 13.79%
2013-12-31 $0.21B $1.48B 14.35%
2013-09-30 $0.22B $1.50B 15.21%
2013-06-30 $0.24B $1.49B 16.55%
2013-03-31 $0.24B $1.44B 18.48%
2012-12-31 $0.25B $1.44B 20.77%
2012-09-30 $0.24B $1.32B 21.73%
2012-06-30 $0.22B $1.04B 22.11%
2012-03-31 $0.22B $1.03B 22.10%
2011-12-31 $0.21B $0.99B 20.59%
2011-09-30 $0.19B $0.99B 18.93%
2011-06-30 $0.20B $1.03B 19.87%
2011-03-31 $0.09B $1.00B 8.93%
2010-12-31 $0.08B $0.96B 8.49%
2010-09-30 $0.10B $0.94B 10.69%
2010-06-30 $0.10B $0.91B 9.99%
2010-03-31 $0.20B $0.96B 20.44%
2009-12-31 $0.20B $1.04B 20.22%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $19.157B $4.585B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $220.806B 23.09
Edwards Lifesciences (EW) United States $47.328B 32.57
Alcon (ALC) Switzerland $34.365B 29.59
Teleflex (TFX) United States $11.378B 18.46
Fresenius Medical Care AG KGaA (FMS) Germany $9.600B 9.64
Penumbra (PEN) United States $8.008B 1916.82
Globus Medical (GMED) United States $7.483B 38.05
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96
Artivion (AORT) United States $0.546B 0.00